Tehran University of Medical Sciences

Science Communicator Platform

Share By
Design, Synthesis, in Vitro, and in Silico Studies on Promising Α-Glucosidase Inhibitors Based on a Quinazolinone–Thiophene Scaffold Publisher



Baghershahi P ; Dastyafteh N ; Halimi M ; Mohammadikhanaposhtani M ; Ghafouri SN ; Noori M ; Ghasemi F ; Mojtabavi S ; Faramarzi MA ; Torabi M ; Alikhani M ; Larijani B ; Javanshir S ; Mahdavi M
Authors

Source: RSC Advances Published:2026


Abstract

To discover novel inhibitors for α-glucosidase, a new scaffold featuring a quinazolinone–thiophene skeleton was designed through molecular hybridization. Eighteen derivatives, 14a–f, 15a–f, and 19a–f, were synthesized from this scaffold. These compounds were tested against yeast α-glucosidase. The in vitro enzymatic assays showed that all but one of the new compounds were active against α-glucosidase. The most potent compound was 19d, which inhibited the activity 11.7 times more effectively than acarbose, a standard inhibitor. In vitro kinetic studies demonstrated that this compound is a competitive inhibitor. Furthermore, in silico docking studies showed that compound 19d interacts with key residues in the active sites of both homology-modeled yeast and human α-glucosidase with favorable binding energies. Additionally, molecular dynamics simulations indicated that 19d formed a stable complex with this enzyme. Density functional theory (DFT) calculations provided further insight into the potency of the lead compounds. Based on the in vitro results, the most potent compounds were further examined in silico for druglikeness, pharmacokinetics, and toxicity. These evaluations revealed that, in terms of druglikeness and pharmacokinetics, the new compounds were similar to acarbose, while they showed better toxicity profiles. Furthermore, the most potent compounds exhibited low cytotoxicity against normal NIH-3T3 cells. This journal is © The Royal Society of Chemistry, 2026
Related Docs
View other Related Docs
1. Synthesis, in Vitro, and in Silico Evaluation of Indazole Schiff Bases As Potential Α-Glucosidase Inhibitors, Journal of Molecular Structure (2021)
2. New Benzimidazole–Indole–Amide Derivatives As Potent Α-Glucosidase and Acetylcholinesterase Inhibitors, Archiv der Pharmazie (2025)
3. Design, Synthesis, in Vitro, and in Silico Enzymatic Evaluations of Thieno[2,3-B]Quinoline-Hydrazones As Novel Inhibitors for Α-Glucosidase, Bioorganic Chemistry (2022)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Faramarzi (16)
Mohammad Mahdavi (16)
Other Related Docs
4. Design, Synthesis, and Α-Glucosidase-Inhibitory Activity of Phenoxy-Biscoumarin–N-Phenylacetamide Hybrids, Archiv der Pharmazie (2021)
5. Indole-Carbohydrazide Linked Phenoxy-1,2,3-Triazole-N-Phenylacetamide Derivatives As Potent Α-Glucosidase Inhibitors: Design, Synthesis, in Vitro Α-Glucosidase Inhibition, and Computational Studies, BMC Chemistry (2023)
6. Design and Synthesis of Novel Pyridazine N-Aryl Acetamides: In-Vitro Evaluation of Α-Glucosidase Inhibition, Docking, and Kinetic Studies, Bioorganic Chemistry (2020)
7. Quinazolinone-Dihydropyrano[3,2-B]Pyran Hybrids As New Α-Glucosidase Inhibitors: Design, Synthesis, Enzymatic Inhibition, Docking Study and Prediction of Pharmacokinetic, Bioorganic Chemistry (2021)
8. Pyrano[2,3-B]Chromone Derivatives As Novel Dual Inhibitors of Α-Glucosidase and Α-Amylase: Design, Synthesis, Biological Evaluation, and in Silico Studies, Bioorganic Chemistry (2024)
9. Discovery of Phthalimide-1,2,3-Triazole-N-Phenylacetamide Hybrids As Potent Α-Glucosidase Inhibitors: Design, Synthesis, Admet Prediction, and in Vitro and in Silico Enzymatic Evaluations, ChemistrySelect (2023)
10. In Silico and in Vitro Studies of Thiosemicarbazone-Indole Hybrid Compounds As Potent Α-Glycosidase Inhibitors, Computational Biology and Chemistry (2022)
11. Synthesis, in Vitro and in Silico Screening of 2-Amino-4-Aryl-6-(Phenylthio) Pyridine-3,5-Dicarbonitriles As Novel Α-Glucosidase Inhibitors, Bioorganic Chemistry (2020)
12. Synthesis and Biological Evaluation of a New Series of Benzofuran-1,3,4-Oxadiazole Containing 1,2,3-Triazole-Acetamides As Potential Α-Glucosidase Inhibitors, Journal of Biochemical and Molecular Toxicology (2021)
13. New Coumarin–Chalcone–Triazole Hybrids As Promising Anti-Diabetic Agents: From Molecular Design to in Vivo Validation, RSC Advances (2025)
14. Design, Synthesis, in Vitro Anti-Α-Glucosidase Evaluations, and Computational Studies of New Phthalimide-Phenoxy-1,2,3-Triazole-N-Phenyl (Or Benzyl) Acetamides As Potential Anti-Diabetic Agents, Scientific Reports (2023)
15. Enzyme Inhibition, Kinetic, and Molecular Docking Studies of Α-Glucosidase, Current Enzyme Inhibition (2020)
16. Design, Synthesis, in Vitro, and in Silico Studies of Novel Diarylimidazole-1,2,3-Triazole Hybrids As Potent Α-Glucosidase Inhibitors, Bioorganic and Medicinal Chemistry (2019)
17. Design, Synthesis, in Vitro, and in Silico Biological Evaluations of Coumarin-Indole Hybrids As New Anti-Α-Glucosidase Agents, BMC Chemistry (2022)
18. Benzimidazole-Phenoxy-1,2,3-Triazole-Benzyl Derivatives As the New Potent Α-Glucosidase Inhibitors: Design, Synthesis, in Vitro, and in Silico Biological Evaluations, Current Organic Synthesis (2025)
19. New Quinoxalin-1,3,4-Oxadiazole Derivatives: Synthesis, Characterization, in Vitro Biological Evaluations, and Molecular Modeling Studies, Archiv der Pharmazie (2021)
20. Design and Synthesis of Novel Quinoline-Piperazines Fused to a Phenylhydrazinecarbothioamide Scaffold As Promising Α-Glucosidase Inhibitors With Anti-Diabetic Potential, Future Medicinal Chemistry (2025)